483
Shandong Ruiying Pioneer Pharmaceutical Co., LtdFDA 483 - Shandong Ruiying Pioneer Pharmaceutical Co., Ltd - March 18, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Shandong Ruiying Pioneer Pharmaceutical Co., Ltd. in Heze City, China, from March 18-22, 2019, revealed two significant observations. The firm was cited for inadequate qualification of equipment used in API manufacturing. Additionally, deficient warehouse cleaning practices were observed, including rust, heavy dust accumulation, and a lack of cleaning records.
- Inspection Date
- March 18, 2019
- Product Type
- Drugs
Open in Dashboard
ID · 52038d75-de94-439b-bb4e-2c201838962f